Debate Over Sinovac Jab For Kids

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-11-15 HKT 14:26

Share this story

facebook

  • A government advisory panel will meet on Monday to discuss whether children as young as three years old should be allowed to get a Sinovac jab. Image: Shutterstock

    A government advisory panel will meet on Monday to discuss whether children as young as three years old should be allowed to get a Sinovac jab. Image: Shutterstock

Two medical professionals on Monday offered mixed views on whether children as young as three years old should be allowed to get a Sinovac jab ahead of a government advisory panel meeting to discuss the matter.

Sinovac has requested the administration to allow children aged three or above here to get a jab, which is currently only available for people aged 18 or above.

Respiratory medicine expert Leung Chi-chiu believes it is time to lower the age limit, saying many people have got the vaccine around the world without rare adverse events.

Leung pointed out that the Sinovac jab is being given to children aged three or older on the mainland. "Other countries like Chile and Colombia have also extended the age of application down to either six or three," he added.

He said getting younger children vaccinated will help prevent any future outbreaks of the virus.

But president of the Society of Hospital Pharmacists, William Chui, said more information is needed about the Sinovac jab.

He said that while more than 100 million children have already received the vaccine on the mainland, "the problem is we have to know the distribution of age groups, especially for children [aged between] three to five years old, as they are very vulnerable."

Chui called on the authorities to ask Sinovac for more information, saying it published "limited" data in Lancet in June, with only 56 children aged between three and five and 81 aged between six and 11 being involved.

The pharmacist also said the authorities could consider lowering the age limit for the BioNTech vaccine – available currently to local youngsters aged 12 and above – so parents can have a choice.

RECENT NEWS

TOPPAN Edge Becomes Japans First Qualified VLEI Issuer

The Global Legal Entity Identifier Foundation (GLEIF) has announced TOPPAN Edge, a subsidiary of TOPPAN Holdings that p... Read more

SFC And Dubais DFSA Partner On Cross-Border Regulatory Cooperation

The Dubai Financial Services Authority (DFSA), the independent regulator of the Dubai International Financial Centre (D... Read more

Toss To Launch Finance Super-App In Australia, Plans Won-Based Stablecoin

South Korea’s fintech unicorn Toss is preparing to launch its finance super-app in Australia before the end of this y... Read more

China Funds Research On Stablecoins And Cross-Border Oversight

China’s largest government-backed research funder has begun accepting applications for studies on stablecoins and the... Read more

XTransfer, CZBank Shanghai Branch Form Cross-Border Finance Partnership

XTransfer has entered into a partnership with the Shanghai branch of China Zheshang Bank (CZBank). The agreement was si... Read more

Brinc Launches VentureVerse Through Acquisition Of OG Club

Brinc, a Hong Kong-based venture acceleration and corporate innovation firm, has acquired OG Club, a decentralised auto... Read more